Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2024)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -53.46% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 99.48% |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 147.23% |
| Dec 31, 2020 | -164.51% |
| Dec 31, 2015 | 64.48% |
| Sep 30, 2015 | 99.18% |
| Jun 30, 2015 | 84.68% |
| Dec 31, 2014 | 54.96% |
| Sep 30, 2014 | 67.60% |
| Jun 30, 2014 | 58.71% |
| Mar 31, 2014 | 59.97% |
| Dec 31, 2013 | -47.32% |
| Sep 30, 2013 | -149.75% |
| Jun 30, 2013 | -237.87% |
| Mar 31, 2013 | -777.00% |
| Dec 31, 2012 | -193.84% |
| Sep 30, 2012 | -69.23% |
| Jun 30, 2012 | 829.79% |
| Mar 31, 2012 | -80.75% |
| Dec 31, 2011 | -783.53% |
| Sep 30, 2011 | -436.56% |
| Jun 30, 2011 | -167.84% |